Position in TEVA
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$3,613,163
+$647,460 QoQ
Shares Held
106,646
+8.3% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#214
of 671 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026M&T Bank Corp holds $21,859,084 across 15 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (16.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
120,970 | $8,692,898 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
106,646 | $3,613,163 | |
| 3 | VTRS |
Viatris Inc
|
101,570 | $1,612,928 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
85,032 | $1,363,060 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
2,500 | $1,354,567 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
8,222 | $912,145 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
23,020 | $798,100 | |
| 8 | HLN |
Haleon plc
|
78,524 | $732,626 |
All Filings in TEVA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,613,163 | 106,646 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $2,965,703 | 98,463 | Shares | Defined | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||